search
Back to results

A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain

Primary Purpose

Coronary Artery Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
64 Channel VCT
Sponsored by
GE Healthcare
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring CT, Coronary, Cardiac, Angiography, X-ray, CAD, Chest pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: The subject has typical or atypical chest pain suspected of CAD and is referred for an elective coronary angiography. The subject must be scheduled to undergo a CATH procedure between 48 hours and 3 weeks post CCTA procedure. The subject must not undergo any cardiac interventional treatment between the 2 procedures. The subject must have sinus rhythm with stable heart rate of ≤65 beats per minute (bpm) or if heart rate was >65 bpm, the subject must agree to the use of beta-blocker(s) prior to the CT scan procedure to achieve stable heart rate of ≤65 bpm. Exclusion Criteria: The subject had an established diagnosis of CAD by a) previous CATH, b) prior myocardial infarction confirmed by ECG, or c) prior revascularization (balloon angioplasty, stent placement, or CABG). The subject had a known allergy to iodinated contrast agent, including but not limited to hives, anaphylactoid or cardiovascular reactions, laryngeal edema and bronchospasm. The subject had impaired renal function with a serum creatinine level of 1.7 mg/dL (150 μmol/L) or above. The subject had atrial fibrillation/flutter or any irregular heart rhythm considered by the investigator to interfere with temporal acquisition of cardiac CT images. The subject had a resting heart rate of >100 bpm and/or a resting systolic blood pressure of <100mm Hg. The subject had an artificial heart valve(s). The subject has had prior pacemaker or internal defibrillator lead implantation. The subject's resting heart rate was >65 bpm and beta-blocker therapy was contraindicated. The subject had a contraindication to verapamil when beta-blocker therapy could not be administered. The subject had a contraindication to nitroglycerin. The subject had evidence of ongoing or active clinical instability.

Sites / Locations

  • Robert Centofanti, MS

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

64 Channel VCT

Arm Description

All subjects underwent Coronary Computed Tomographic Angiography (CCTA) after receiving an intravenous (IV) administration of Visipaque (320 mgI/mL), to be followed 2 to 21 days later by catheter coronary angiography (CATH).

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
June 30, 2006
Last Updated
April 25, 2019
Sponsor
GE Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT00348569
Brief Title
A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain
Official Title
A Prospective, Multicenter Study of GE LightSpeed Volume Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain Patients Suspected of Coronary Artery Disease
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
May 2006 (undefined)
Primary Completion Date
January 31, 2007 (Actual)
Study Completion Date
January 31, 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
GE Healthcare

4. Oversight

5. Study Description

Brief Summary
To compare computed tomography (CT) images (pictures) of the coronary arteries using the General Electric (GE) LightSpeed VCT scanner with x-ray coronary angiography in patients with typical or atypical chest pain suspected of coronary artery disease (CAD).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
CT, Coronary, Cardiac, Angiography, X-ray, CAD, Chest pain

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
245 (Actual)

8. Arms, Groups, and Interventions

Arm Title
64 Channel VCT
Arm Type
Experimental
Arm Description
All subjects underwent Coronary Computed Tomographic Angiography (CCTA) after receiving an intravenous (IV) administration of Visipaque (320 mgI/mL), to be followed 2 to 21 days later by catheter coronary angiography (CATH).
Intervention Type
Device
Intervention Name(s)
64 Channel VCT

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The subject has typical or atypical chest pain suspected of CAD and is referred for an elective coronary angiography. The subject must be scheduled to undergo a CATH procedure between 48 hours and 3 weeks post CCTA procedure. The subject must not undergo any cardiac interventional treatment between the 2 procedures. The subject must have sinus rhythm with stable heart rate of ≤65 beats per minute (bpm) or if heart rate was >65 bpm, the subject must agree to the use of beta-blocker(s) prior to the CT scan procedure to achieve stable heart rate of ≤65 bpm. Exclusion Criteria: The subject had an established diagnosis of CAD by a) previous CATH, b) prior myocardial infarction confirmed by ECG, or c) prior revascularization (balloon angioplasty, stent placement, or CABG). The subject had a known allergy to iodinated contrast agent, including but not limited to hives, anaphylactoid or cardiovascular reactions, laryngeal edema and bronchospasm. The subject had impaired renal function with a serum creatinine level of 1.7 mg/dL (150 μmol/L) or above. The subject had atrial fibrillation/flutter or any irregular heart rhythm considered by the investigator to interfere with temporal acquisition of cardiac CT images. The subject had a resting heart rate of >100 bpm and/or a resting systolic blood pressure of <100mm Hg. The subject had an artificial heart valve(s). The subject has had prior pacemaker or internal defibrillator lead implantation. The subject's resting heart rate was >65 bpm and beta-blocker therapy was contraindicated. The subject had a contraindication to verapamil when beta-blocker therapy could not be administered. The subject had a contraindication to nitroglycerin. The subject had evidence of ongoing or active clinical instability.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Centofanti, MS
Organizational Affiliation
GE Healthcare
Official's Role
Study Director
Facility Information:
Facility Name
Robert Centofanti, MS
City
Princeton
State/Province
New Jersey
ZIP/Postal Code
08540
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
21696739
Citation
Min JK, Edwardes M, Lin FY, Labounty T, Weinsaft JW, Choi JH, Delago A, Shaw LJ, Berman DS, Budoff MJ. Relationship of coronary artery plaque composition to coronary artery stenosis severity: results from the prospective multicenter ACCURACY trial. Atherosclerosis. 2011 Dec;219(2):573-8. doi: 10.1016/j.atherosclerosis.2011.05.032. Epub 2011 May 31.
Results Reference
derived
PubMed Identifier
19007693
Citation
Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008 Nov 18;52(21):1724-32. doi: 10.1016/j.jacc.2008.07.031.
Results Reference
derived

Learn more about this trial

A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain

We'll reach out to this number within 24 hrs